FDA 483 - PEL Healthcare LLC - January 13, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
PEL Healthcare LLC, a drug product manufacturer in Sellersville, PA, was cited for significant deficiencies in its quality system and laboratory controls during an FDA inspection. Observations included a failure to thoroughly investigate unexplained discrepancies and out-of-specification results, as well as inadequate laboratory control procedures for chromatographic analyses and equipment calibration. These issues raise concerns about the scientific soundness and reliability of product release testing.
ID · e671146b-2f23-4e31-acb1-d4b2d2077111